Abstract
Pain is among the most common symptoms in patients with pancreatic cancer and up to 80% require analgesics, most often as opioids. Unfortunately the analgesic effect is frequently insufficient, and increasing doses are required, resulting in unpleasant side effects. Endoscopic ultrasound-guided neurolysis is a well established method to alleviate or reduce pain due to pancreatic cancer with a documented effect in 80% of patients. The aim of this review is to draw attention to endoscopic ultrasound-guided neurolysis and to discuss its potential which may not be fully utilized.
| Translated title of the contribution | Endoscopic ultrasound-guided coeliac plexus neurolysis to reduce pain in patients with pancreatic cancer. |
|---|---|
| Original language | Danish |
| Article number | V07140404 |
| Journal | Ugeskrift for Laeger |
| Volume | 176 |
| Pages (from-to) | 2-5 |
| Number of pages | 4 |
| ISSN | 0041-5782 |
| Publication status | Published - 2014 |
